Janux Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
JANX Nasdaq 2834 www.januxrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Janux Therapeutics, Inc.

Janux Therapeutics (JANX) Is Up 7.1% After Reporting Narrower Net Losses And Improved Earnings Profile - Aug 11th, 2026 4:10 am
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2026 3:20 pm
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights - Aug 6th, 2026 2:02 pm
3 Small-Cap Biotech Stocks Pairing Rapid Revenue Growth With High Insider Ownership - Jul 23rd, 2026 11:56 pm
Is Janux Therapeutics’ (JANX) Russell Index Exit Quietly Rewriting Its Investor Base and Story? - Jul 9th, 2026 3:10 am
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone - Jul 2nd, 2026 4:40 pm
Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential? - Jun 30th, 2026 7:06 am
Akari Therapeutics Highlights 1st ASCO Abstract Acceptance - May 28th, 2026 4:33 pm
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC - May 28th, 2026 10:53 am
Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know - May 28th, 2026 7:55 am
Here's Why You Should Add JANX Stock to Your Portfolio Now - May 26th, 2026 9:28 am
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch - May 23rd, 2026 2:48 pm
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - May 23rd, 2026 2:37 pm
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 5:05 pm
How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44% - May 7th, 2026 7:55 am
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results - Apr 28th, 2026 3:57 am
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool - Apr 17th, 2026 4:04 am
Will Health Benefits Weakness Drag Elevance's Q1 Earnings? - Apr 16th, 2026 11:33 am
Sector Update: Health Care Stocks Decline Late Afternoon - Apr 15th, 2026 1:56 pm
Sector Update: Health Care Stocks Lower in Afternoon Trading - Apr 15th, 2026 11:55 am